Intel Corporation 10-Q Summary: Quarter Ended March 29, 2003
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 29, 2003. Intel Corporation operates as a leading supplier of silicon and integrated networking building blocks, organized into three primary operating segments: Intel Architecture Business, Wireless Communications and Computing Group (WCCG), and Intel Communications Group (ICG). The company reported a seasonal quarter with flat revenue compared to the prior year, driven by the Intel Architecture business performing at the high end of seasonal expectations.
Key Financial Metrics
| Metric (in millions) | Q1 2003 | Q1 2002 |
|---|---|---|
| Net Revenue | $6,751 | $6,781 |
| Gross Margin | $3,512 (52.0%) | $3,480 (51.3%) |
| Operating Income | $1,391 | $1,315 |
| Net Income | $915 | $936 |
| Diluted EPS | $0.14 | $0.14 |
| Cash from Operating Activities | $1,710 | $1,528 |
| Cash and Cash Equivalents (End of Period) | $7,134 | $6,524 |
| Total Debt (Short + Long Term) | $1,222 | N/A |
Segment Performance: The Intel Architecture Business generated $5.76 billion in revenue and $1.91 billion in operating income. WCCG reported $473 million in revenue and a $94 million operating loss. ICG reported $503 million in revenue and a $140 million operating loss.
Material Changes vs. Prior Period
- Revenue: Flat year-over-year. Higher unit sales of microprocessors in the Intel Architecture segment were offset by lower average selling prices. WCCG revenue increased slightly due to application processors, while ICG revenue declined due to lower telecom product sales.
- Profitability: Operating income increased by $76 million, primarily due to the absence of a $155 million Intergraph settlement charge recorded in Q1 2002 and the sale of previously reserved inventory in Q1 2003. These gains were partially offset by lower average selling prices and increased start-up costs for 300mm wafer and 0.13-micron technology manufacturing.
- Equity Losses: Net losses on equity securities increased to $127 million from $46 million, driven by $140 million in impairment charges on non-marketable equity securities.
- Capital Expenditures: Additions to property, plant, and equipment decreased to $954 million from $1.43 billion in the prior year.
Guidance, Outlook, and Risks
Q2 2003 Guidance:
- Revenue: Expected between $6.4 billion and $7.0 billion (midpoint slightly down from Q1).
- Gross Margin: Expected to be approximately 50% (+/- a couple of points), down from 52% in Q1 due to higher start-up costs and the non-recurrence of inventory reserve benefits.
- Operating Expenses: R&D and SG&A expected between $2.0 billion and $2.1 billion.
- Equity Losses: Expected net loss of $20 million, primarily from $60 million in impairment charges.
Full Year 2003 Outlook:
- Gross Margin: Expected to be 51% (+/- a few points).
- Capital Spending: Expected between $3.5 billion and $3.9 billion, down from $4.7 billion in 2002.
- Depreciation: Expected to be $4.8 billion.
Risks and Contingencies:
- Legal Proceedings: Ongoing litigation includes patent disputes with Broadcom (trial set for July 2003) and Intergraph (Intel paid $150 million pending appeal; potential additional $100 million liability if appeal fails). A settlement with VIA Technologies was reached in April 2003 with no material financial impact.
- Market Conditions: Continued uncertainty in global economic conditions and the telecommunications industry. Demand for flash memory remains uncertain.
- Impairment Risks: Significant exposure to non-marketable equity securities ($643 million carrying value) which may face further impairments if investees cannot secure funding.
Investor Verification Checklist
- Inventory Reserves: Verify the sustainability of the Q1 gross margin benefit derived from the sale of previously reserved inventory, as management explicitly states this will not recur in Q2.
- Intergraph Litigation: Monitor the status of the appeal regarding the $150 million payment and the potential for an additional $100 million liability.
- Non-Marketable Equity: Assess the risk of further impairment charges on the $643 million portfolio of non-marketable equity securities given the constrained equity market environment.
- Manufacturing Ramp Costs: Track the impact of start-up costs associated with the transition to 300mm wafers and 90-nanometer process technology on future gross margins.
- Capital Efficiency: Evaluate whether the reduced capital spending plan ($3.5B-$3.9B) aligns with projected demand growth to avoid under-utilization of manufacturing capacity.